Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

The Ebola epidemic crystallizes the potential of passive antibody therapy for infectious diseases.

Casadevall A, Pirofski LA.

PLoS Pathog. 2015 Apr 23;11(4):e1004717. doi: 10.1371/journal.ppat.1004717. eCollection 2015 Apr. No abstract available.

2.

What is infectiveness and how is it involved in infection and immunity?

Pirofski LA, Casadevall A.

BMC Immunol. 2015 Mar 26;16:13. doi: 10.1186/s12865-015-0076-1.

3.

Host immunity to Cryptococcus neoformans.

Rohatgi S, Pirofski LA.

Future Microbiol. 2015 Apr;10:565-81. doi: 10.2217/fmb.14.132.

PMID:
25865194
4.

Quantitative and Qualitative Antibody Responses to Immunization With the Pneumococcal Polysaccharide Vaccine in HIV-Infected Patients After Initiation of Antiretroviral Treatment: Results From a Randomized Clinical Trial.

Rodriguez-Barradas MC, Serpa JA, Munjal I, Mendoza D, Rueda AM, Mushtaq M, Pirofski LA.

J Infect Dis. 2015 Jun 1;211(11):1703-11. doi: 10.1093/infdis/jiu819. Epub 2014 Dec 23.

PMID:
25538270
5.

Microbiology: Ditch the term pathogen.

Casadevall A, Pirofski LA.

Nature. 2014 Dec 11;516(7530):165-6. doi: 10.1038/516165a. No abstract available.

PMID:
25503219
6.

What is a host? Incorporating the microbiota into the damage-response framework.

Casadevall A, Pirofski LA.

Infect Immun. 2015 Jan;83(1):2-7. doi: 10.1128/IAI.02627-14. Epub 2014 Nov 10. Review.

PMID:
25385796
7.

An ahemolytic pneumolysin of Streptococcus pneumoniae manipulates human innate and CD4⁺ T-cell responses and reduces resistance to colonization in mice in a serotype-independent manner.

Khan MN, Coleman JR, Vernatter J, Varshney AK, Dufaud C, Pirofski LA.

J Infect Dis. 2014 Nov 15;210(10):1658-69. doi: 10.1093/infdis/jiu321. Epub 2014 Jun 13.

PMID:
25001458
8.

Characterization of protective extracellular membrane-derived vesicles produced by Streptococcus pneumoniae.

Olaya-Abril A, Prados-Rosales R, McConnell MJ, Martín-Peña R, González-Reyes JA, Jiménez-Munguía I, Gómez-Gascón L, Fernández J, Luque-García JL, García-Lidón C, Estévez H, Pachón J, Obando I, Casadevall A, Pirofski LA, Rodríguez-Ortega MJ.

J Proteomics. 2014 Jun 25;106:46-60. doi: 10.1016/j.jprot.2014.04.023. Epub 2014 Apr 24.

PMID:
24769240
9.

Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease.

Rohatgi S, Gohil S, Kuniholm MH, Schultz H, Dufaud C, Armour KL, Badri S, Mailliard RB, Pirofski LA.

MBio. 2013 Aug 27;4(5):e00573-13. doi: 10.1128/mBio.00573-13.

10.

X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans Infection.

Szymczak WA, Davis MJ, Lundy SK, Dufaud C, Olszewski M, Pirofski LA.

MBio. 2013 Jul 2;4(4). pii: e00265-13. doi: 10.1128/mBio.00265-13.

11.

Current concepts in host-microbe interaction leading to pneumococcal pneumonia.

Vernatter J, Pirofski LA.

Curr Opin Infect Dis. 2013 Jun;26(3):277-83. doi: 10.1097/QCO.0b013e3283608419. Review.

12.

Exserohilum rostratum fungal meningitis associated with methylprednisolone injections.

Casadevall A, Pirofski LA.

Future Microbiol. 2013 Feb;8(2):135-7. doi: 10.2217/fmb.12.138. No abstract available.

13.

Molecular characterization of the early B cell response to pulmonary Cryptococcus neoformans infection.

Rohatgi S, Pirofski LA.

J Immunol. 2012 Dec 15;189(12):5820-30. doi: 10.4049/jimmunol.1201514. Epub 2012 Nov 21.

14.

Tissue-expressed B7x affects the immune response to and outcome of lethal pulmonary infection.

Hofmeyer KA, Scandiuzzi L, Ghosh K, Pirofski LA, Zang X.

J Immunol. 2012 Sep 15;189(6):3054-63. doi: 10.4049/jimmunol.1200701. Epub 2012 Aug 1.

15.

Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases.

Casadevall A, Pirofski LA.

Cell Host Microbe. 2012 May 17;11(5):447-56. doi: 10.1016/j.chom.2012.04.004. Review.

16.

IL-23 dampens the allergic response to Cryptococcus neoformans through IL-17-independent and -dependent mechanisms.

Szymczak WA, Sellers RS, Pirofski LA.

Am J Pathol. 2012 Apr;180(4):1547-59. doi: 10.1016/j.ajpath.2011.12.038. Epub 2012 Feb 16.

17.

CD8+ T cells and risk for bacterial pneumonia and all-cause mortality among HIV-infected women.

Gohil SK, Heo M, Schoenbaum EE, Celentano D, Pirofski LA.

J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):191-8. doi: 10.1097/QAI.0b013e31824d90fe.

18.

Q and A: What is a pathogen? A question that begs the point.

Pirofski LA, Casadevall A.

BMC Biol. 2012 Jan 31;10:6. doi: 10.1186/1741-7007-10-6. No abstract available.

19.
20.

A new synthesis for antibody-mediated immunity.

Casadevall A, Pirofski LA.

Nat Immunol. 2011 Dec 16;13(1):21-8. doi: 10.1038/ni.2184.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk